Annual Current Liabilities
$76.06 M
+$18.48 M+32.08%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total current liabilities is currently $76.06 million, with the most recent change of +$18.48 million (+32.08%) on 31 December 2023. During the last 3 years, it has risen by +$53.31 million (+234.25%). CPRX annual current liabilities is now at all-time high.CPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$105.39 M
+$13.08 M+14.17%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total current liabilities is currently $105.39 million, with the most recent change of +$13.08 million (+14.17%) on 30 September 2024. Over the past year, it has increased by +$47.59 million (+82.33%). CPRX quarterly current liabilities is now at all-time high.CPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.1% | +82.3% |
| 3 y3 years | +234.3% | +411.3% |
| 5 y5 years | +699.7% | +486.1% |
CPRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +234.3% | at high | +411.3% |
| 5 y | 5 years | at high | +699.7% | at high | +630.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $105.39 M(+14.2%) |
| June 2024 | - | $92.32 M(+16.0%) |
| Mar 2024 | - | $79.57 M(+4.6%) |
| Dec 2023 | $76.06 M(+32.1%) | $76.06 M(+31.6%) |
| Sept 2023 | - | $57.81 M(+10.1%) |
| June 2023 | - | $52.50 M(-7.4%) |
| Mar 2023 | - | $56.71 M(-1.5%) |
| Dec 2022 | $57.59 M(+112.8%) | $57.59 M(+28.9%) |
| Sept 2022 | - | $44.68 M(+98.7%) |
| June 2022 | - | $22.49 M(-2.0%) |
| Mar 2022 | - | $22.94 M(-15.2%) |
| Dec 2021 | $27.06 M(+18.9%) | $27.06 M(+31.3%) |
| Sept 2021 | - | $20.61 M(+27.8%) |
| June 2021 | - | $16.14 M(+11.8%) |
| Mar 2021 | - | $14.44 M(-36.6%) |
| Dec 2020 | $22.76 M(-5.6%) | $22.76 M(+24.8%) |
| Sept 2020 | - | $18.23 M(-9.8%) |
| June 2020 | - | $20.21 M(+14.6%) |
| Mar 2020 | - | $17.64 M(-26.8%) |
| Dec 2019 | $24.10 M(+153.4%) | $24.10 M(+34.0%) |
| Sept 2019 | - | $17.98 M(+27.1%) |
| June 2019 | - | $14.15 M(+56.8%) |
| Mar 2019 | - | $9.03 M(-5.1%) |
| Dec 2018 | $9.51 M(+122.9%) | $9.51 M(+174.2%) |
| Sept 2018 | - | $3.47 M(+12.5%) |
| June 2018 | - | $3.08 M(+12.8%) |
| Mar 2018 | - | $2.73 M(-36.0%) |
| Dec 2017 | $4.27 M(+103.7%) | $4.27 M(+55.8%) |
| Sept 2017 | - | $2.74 M(+48.8%) |
| June 2017 | - | $1.84 M(-3.4%) |
| Mar 2017 | - | $1.91 M(-9.0%) |
| Dec 2016 | $2.09 M(-39.1%) | $2.09 M(+5.0%) |
| Sept 2016 | - | $2.00 M(-13.4%) |
| June 2016 | - | $2.31 M(-13.5%) |
| Mar 2016 | - | $2.66 M(-22.6%) |
| Dec 2015 | $3.44 M | $3.44 M(+44.2%) |
| Sept 2015 | - | $2.39 M(-6.5%) |
| June 2015 | - | $2.55 M(-56.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $5.85 M(-0.1%) |
| Dec 2014 | $5.86 M(+173.6%) | $5.86 M(-1.4%) |
| Sept 2014 | - | $5.94 M(+151.2%) |
| June 2014 | - | $2.36 M(-3.0%) |
| Mar 2014 | - | $2.44 M(+13.9%) |
| Dec 2013 | $2.14 M(+29.9%) | $2.14 M(-29.0%) |
| Sept 2013 | - | $3.01 M(+83.9%) |
| June 2013 | - | $1.64 M(+66.6%) |
| Mar 2013 | - | $983.20 K(-40.3%) |
| Dec 2012 | $1.65 M(+97.5%) | $1.65 M(+118.6%) |
| Sept 2012 | - | $753.30 K(+11.3%) |
| June 2012 | - | $677.00 K(-23.0%) |
| Mar 2012 | - | $879.30 K(+5.5%) |
| Dec 2011 | $833.80 K(+178.9%) | $833.80 K(+97.3%) |
| Sept 2011 | - | $422.70 K(-35.6%) |
| June 2011 | - | $656.10 K(-23.9%) |
| Mar 2011 | - | $862.30 K(+188.4%) |
| Dec 2010 | $299.00 K(+1.6%) | $299.00 K(-24.5%) |
| Sept 2010 | - | $396.10 K(-12.2%) |
| June 2010 | - | $451.20 K(+34.8%) |
| Mar 2010 | - | $334.70 K(+13.8%) |
| Dec 2009 | $294.20 K(-79.4%) | $294.20 K(+10.7%) |
| Sept 2009 | - | $265.70 K(-43.6%) |
| June 2009 | - | $470.90 K(-69.4%) |
| Mar 2009 | - | $1.54 M(+7.5%) |
| Dec 2008 | $1.43 M(+371.5%) | $1.43 M(+17.2%) |
| Sept 2008 | - | $1.22 M(+64.9%) |
| June 2008 | - | $740.10 K(+68.9%) |
| Mar 2008 | - | $438.10 K(+44.4%) |
| Dec 2007 | $303.30 K(-60.8%) | $303.30 K(-25.1%) |
| Sept 2007 | - | $405.10 K(-3.2%) |
| June 2007 | - | $418.50 K(-20.2%) |
| Mar 2007 | - | $524.30 K(-32.2%) |
| Dec 2006 | $772.80 K(+125.3%) | $772.80 K(+12.6%) |
| Sept 2006 | - | $686.50 K(+58.0%) |
| June 2006 | - | $434.40 K(+26.6%) |
| Dec 2005 | $343.00 K(+405.9%) | $343.00 K(+405.9%) |
| Dec 2004 | $67.80 K | $67.80 K |
FAQ
- What is Catalyst Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual current liabilities year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly current liabilities year-on-year change?
What is Catalyst Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CPRX is $76.06 M
What is the all time high annual current liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total current liabilities is $76.06 M
What is Catalyst Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CPRX annual total current liabilities has changed by +$18.48 M (+32.08%)
What is Catalyst Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CPRX is $105.39 M
What is the all time high quarterly current liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total current liabilities is $105.39 M
What is Catalyst Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CPRX quarterly total current liabilities has changed by +$47.59 M (+82.33%)